RESPIRA THERAPEUTICS
Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its patent pending technology for passive dry powder inhalers (DPI), consisting of a unique drug delivery engine with a novel, patent pending mechanism of action for lung delivery and therapy. Clinical proof-of-... principle has been achieved. Respira Therapeutics DPIs have demonstrated "best-in-class" drug dispersion performance, and are uniquely positioned to replace currently marketed devices and to broaden inhaled therapies to drug classes/disease indications in high value therapeutic areas by virtue of superior performance and payload outcomes.
RESPIRA THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2010-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.respiratherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
5058201832
Email Addresses:
[email protected]
Total Funding:
5.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Current Advisors List
Current Employees Featured
Founder
Investors List
Keiretsu Forum Northwest
Keiretsu Forum Northwest investment in Series B - Respira Therapeutics
Sun Mountain Capital
Sun Mountain Capital investment in Convertible Note - Respira Therapeutics
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Convertible Note - Respira Therapeutics
Sun Mountain Capital
Sun Mountain Capital investment in Convertible Note - Respira Therapeutics
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Convertible Note - Respira Therapeutics
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Series A - Respira Therapeutics
Sun Mountain Capital
Sun Mountain Capital investment in Series A - Respira Therapeutics
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Series A - Respira Therapeutics
Official Site Inspections
http://www.respiratherapeutics.com Semrush global rank: 5.56 M Semrush visits lastest month: 1.52 K
- Host name: box595.bluehost.com
- IP address: 66.147.242.195
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Respira Therapeutics"
Respira Therapeutics
Respira has received reports of employment scams that purport to extend job offers or seek financial commitments from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text …See details»
About Us – Respira Therapeutics
You may report any such behavior via [email protected]. If you have been defrauded or suspect identity theft as a result of an employment scam, please contact your local law …See details»
Respira Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 5058201832 Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory …See details»
Respira Therapeutics, Inc. | LinkedIn
Respira Therapeutics, Inc. | 1,638 followers on LinkedIn. Improving patient outcomes through enhanced drug targeting to the lung | Respira Therapeutics is developing inhaled therapeutics …See details»
Respira Therapeutics, Inc. Company Profile | Palo Alto, CA ...
Find company research, competitor information, contact details & financial data for Respira Therapeutics, Inc. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Respira Therapeutics, Inc. Management Team | Org Chart
Respira Therapeutics, Inc. employs 18 employees. The Respira Therapeutics, Inc. management team includes John Kollins (CEO and Corporate Director), Kathy Feldkircher (Vice President, …See details»
Respira Therapeutics, Inc. Information - RocketReach
Respiratherapeutics.com; 1 469400XXXX; View Similar People. Related Companies Simplee. 13 $14m Cognoa. 48 $9.9m Eiger BioPharmaceuticals. 31 $11.2m EW Healthcare Partners. 30 …See details»
Respira - VentureRadar
"Respira is a clinical-stage inhaled therapeutics company developing next-generation pulmonary targeted therapeutics to address significant unmet patient needs in cardio-pulmonary diseases.See details»
Respira Therapeutics - Overview, News & Similar companies
Oct 16, 2020 Respira Therapeutics contact info: Phone number: (505) 200-9557 Website: www.respiratherapeutics.com What does Respira Therapeutics do? Respira Therapeutics is a …See details»
Respira Therapeutics - Craft
Respira Therapeutics is a company developing therapeutic products for unmet patient needs. It provides cardiopulmonary disease-targeted inhalation treatments that enhance drug delivery …See details»
Respira Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 5901 Indian School Road NE #107. Albuquerque, New Mexico, 87110, United States. 505-200-9557See details»
Sage Represents Respira Therapeutics - Opportunity to
Aug 19, 2020 Respira is a privately funded US-based company focused on treatment of cardiopulmonary disease using a novel delivery method of its lead compound RT234 …See details»
Respira Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Respira Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 1 news, and 11 literature, Drug:Vardenafil ...See details»
Pipeline – Respira Therapeutics
Respira’s lead drug-device product candidate, RT234-PAH, is a first-in-class inhaled therapy intended for as-needed (PRN) use to improve exercise tolerance and provide acute relief from …See details»
Respira Therapeutics, Inc. Announces Investment and
Dec 18, 2013 Respira Therapeutics, Inc. Is Developing Inhaled Prescription Pharmaceutical Products Employing Its Breakthrough High Efficiency, Dry Powder Inhaler (DPI) TechnologiesSee details»
Respira Therapeutics Introduces Breakthrough Solutions For …
Jun 9, 2011 Respira Therapeutics is focused on the $52 Billion inhaled therapeutics market. A game-changing advancement over current state-of-the-art inhalers, the Company's patented …See details»
pipeline - Respira Therapeutics
© 2022 Respira Therapeutics Inc. – Palo Alto, CASee details»
Respira Therapeutics Regains North America Rights from United ...
ALBUQUERQUE, N.M., Oct. 10, 2019 /PRNewswire/ -- Respira Therapeutics, a clinical-stage specialty pharmaceutical company developing next-generation cardiopulmonary disease …See details»
Respira Therapeutics Announces First Patient Dosed in Phase 2b …
Apr 5, 2022 It is hypothesized that inhaled RT234 (vardenafil inhalation powder) may provide a therapeutic benefit for acute use in patients with World Health Organization (WHO) Group 1 …See details»
Effect of pulmonary rehabilitation for patients with long COVID …
Mar 13, 2025 The World Health Organization (WHO) defines long COVID-19 symptoms as new symptoms that occur beyond 3 months after infection or more severe symptoms than those …See details»